D. Demarquay

发表

Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric Gα/Gβγ Protein Complex

D. Zaharevitz, E. Bruyneel, S. Holbeck, 2006 .

Stimulation by GH of IGF1 proforms synthesized by rabbit chondrocytes cultured with bFGF in serum-free medium.

R. Hintz, D. Demarquay, M. Corvol, 1992, Experimental cell research.

Role of cyclic AMP in the modulation of IgE production by the beta 2-adrenoceptor agonist, fenoterol.

V. Lagente, O. Coqueret, D. Demarquay, 1996, The European respiratory journal.

Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60 cells.

C. Bailly, A. Lansiaux, D. Bigg, 2001, Molecular pharmacology.

Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues.

A. Rolland, P. Kasprzyk, G. Prévost, 1998, Journal of medicinal chemistry.

Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins.

C. Bailly, A. Rolland, D. Bigg, 2000, Journal of medicinal chemistry.

Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.

C. Bailly, A. Lansiaux, D. Bigg, 1999, Biochemistry.

Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.

R. Kiss, C. Bailly, P. Kasprzyk, 1999, Cancer research.

BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo.

P. Kasprzyk, G. Prévost, D. Bigg, 2004, Cancer research.

Proliferation of Human Tumor Cells in Vitro and in Vivo BN 80927 : A Novel Homocamptothecin That Inhibits

P. Kasprzyk, G. Prévost, D. Bigg, 2004 .

BN 80927: a novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II.

A. Rolland, D. Bigg, O. Lavergne, 1999, Bioorganic & medicinal chemistry letters.

In vitro insulin-like growth factor I interaction with cartilage cells derived from postnatal animals.

V. Nataf, D. Demarquay, L. Tsagris, 1990, Hormone Research.

The Dual Topoisomerase Inhibitor, BN 80927, Is Highly Potent against Cell Proliferation and Tumor Growth

P. Kasprzyk, D. Bigg, H. Coulomb, 2000, Annals of the New York Academy of Sciences.

Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.

D. Zaharevitz, E. Bruyneel, S. Holbeck, 2006, Cancer research.

A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38.

W. Laine, B. Baldeyrou, D. Bigg, 2001, Anti-cancer drug design.

The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison

C. Bailly, P. Kasprzyk, D. Bigg, 2001, Anti-cancer drugs.

Homocamptothecins: E‐Ring Modified CPT Analogues

P. Kasprzyk, D. Bigg, O. Lavergne, 2000, Annals of the New York Academy of Sciences.